Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety

Authors Pouratian, Thakkar, Kim, Bronstein J

Received 12 June 2012

Accepted for publication 27 July 2012

Published 4 September 2012 Volume 2012:2 Pages 107—117


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Nader Pouratian,1,2 Sandeep Thakkar,3 Won Kim,1 Jeff M Bronstein3–5

Departments of Neurosurgery, 2Bioengineering, 3Neurology, 4Brain Research Institute, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles, 5Veterans Administration, Southwest Parkinson’s Disease Reseach, Education, and Clinical Center Los Angeles, CA, USA

Abstract: Deep brain stimulation (DBS) surgery has become increasingly utilized in the treatment of advanced Parkinson’s disease. Over the past decade, a number of studies have demonstrated that DBS is superior to best medical management in appropriately selected patients. The primary targets for DBS in Parkinson’s disease include the subthalamic nucleus and the internal segment of the globus pallidus, both of which improve the cardinal motor features in Parkinson’s disease. Recent randomized studies have revealed that both targets are similarly effective in treating the motor symptoms of Parkinson’s disease, but emerging evidence suggests that the globus pallidus may be the preferred target in many patients, based on differences in nonmotor outcomes. Here, we review appropriate patient selection, and the efficacy and safety of DBS therapy in Parkinson’s disease. Best outcomes are achieved if the problems of the individual patient are considered when evaluating surgical candidates and considering whether the subthalamic nucleus or the globus pallidus internus should be targeted.

Keywords: Parkinson’s disease, deep brain stimulation, subthalamic nucleus, globus pallidus, dyskinesia

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.